Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-21-000090
Accepted
2021-01-11 00:16:17
Documents
1
Effectiveness Date
2021-01-08
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 600
  Complete submission text file 9999999995-21-000090.txt   1699
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-251308 | Film No.: 21518958
SIC: 2834 Pharmaceutical Preparations